An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

The Froedtert & MCW health network has been using the Xealth digital health platform, which is integrated into its EHR system ...

With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies ...

The Committee for Medicinal Products for Human Use adopted a positive opinion for NVS' Kisqali to help reduce the risk of recurrence in people with HR+/HER2- early breast cancer.

Terns Pharmaceuticals' (TERN) stock has risen somewhat due to some optimism around its early-stage clinical programs ...

In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in ...

BP’s program includes a novel PSMA-binding molecule that may be a potential next-generation radioligand therapy (RLT) for prostate cancer and is currently being studied in two investigator-initiated ...

Global Clostridium Difficile Infections Treatment MarketThe global Clostridium Difficile Infections (CDI) treatment market is ...

Under the revised agreement, both companies will co-develop four Radio-DARPin programs; each company will have the right to commercialize two programs (previously one each) Molecular Partners will ...

Founder of the artificial intelligence R&D lab says scientific understanding can prevent mis-steps in developing the technology ...

Contact lenses industry is projected to witness a CAGR of 6.5% during the period 2024-2032. This growth can be attributed to ...

Throughout the month of October, Shanghai has been a hub of various activities aimed at raising awareness about breast cancer ...